Aspira Women's Health Future Growth
Future criteria checks 2/6
Aspira Women's Health is forecast to grow earnings and revenue by 15.4% and 30.7% per annum respectively while EPS is expected to grow by 30.5% per annum.
Key information
15.4%
Earnings growth rate
30.5%
EPS growth rate
Medical Equipment earnings growth | 15.9% |
Revenue growth rate | 30.7% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 14 Aug 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 34 | -10 | N/A | -2 | 3 |
12/31/2025 | 20 | -15 | N/A | -6 | 4 |
12/31/2024 | 10 | -16 | N/A | -14 | 3 |
6/30/2024 | 9 | -16 | -15 | -15 | N/A |
3/31/2024 | 9 | -15 | -15 | -15 | N/A |
12/31/2023 | 9 | -17 | -16 | -16 | N/A |
9/30/2023 | 9 | -18 | -20 | -20 | N/A |
6/30/2023 | 9 | -21 | -24 | -24 | N/A |
3/31/2023 | 9 | -27 | -27 | -27 | N/A |
12/31/2022 | 8 | -30 | -31 | -31 | N/A |
9/30/2022 | 8 | -34 | -32 | -32 | N/A |
6/30/2022 | 7 | -36 | -32 | -32 | N/A |
3/31/2022 | 7 | -35 | -33 | -32 | N/A |
12/31/2021 | 7 | -32 | -28 | -27 | N/A |
9/30/2021 | 6 | -29 | -25 | -25 | N/A |
6/30/2021 | 6 | -23 | -20 | -20 | N/A |
3/31/2021 | 5 | -20 | -17 | -16 | N/A |
12/31/2020 | 5 | -18 | -15 | -15 | N/A |
9/30/2020 | 5 | -15 | -13 | -13 | N/A |
6/30/2020 | 5 | -15 | -13 | -13 | N/A |
3/31/2020 | 5 | -15 | -13 | -13 | N/A |
12/31/2019 | 5 | -15 | -13 | -13 | N/A |
9/30/2019 | 4 | -15 | -13 | -12 | N/A |
6/30/2019 | 4 | -14 | -11 | -11 | N/A |
3/31/2019 | 3 | -12 | -10 | -10 | N/A |
12/31/2018 | 3 | -11 | -9 | -9 | N/A |
9/30/2018 | 3 | -12 | -9 | -9 | N/A |
6/30/2018 | 3 | -12 | -9 | -9 | N/A |
3/31/2018 | 3 | -12 | N/A | -8 | N/A |
12/31/2017 | 3 | -11 | N/A | -8 | N/A |
9/30/2017 | 3 | -11 | N/A | -9 | N/A |
6/30/2017 | 3 | -11 | N/A | -10 | N/A |
3/31/2017 | 3 | -13 | N/A | -11 | N/A |
12/31/2016 | 3 | -15 | N/A | -14 | N/A |
9/30/2016 | 2 | -17 | N/A | -16 | N/A |
6/30/2016 | 2 | -19 | N/A | -17 | N/A |
3/31/2016 | 2 | -20 | N/A | -19 | N/A |
12/31/2015 | 2 | -19 | N/A | -18 | N/A |
9/30/2015 | 3 | -18 | N/A | -18 | N/A |
6/30/2015 | 3 | -19 | N/A | -19 | N/A |
3/31/2015 | 3 | -19 | N/A | -18 | N/A |
12/31/2014 | 3 | -19 | N/A | -17 | N/A |
9/30/2014 | 3 | -17 | N/A | -15 | N/A |
6/30/2014 | 3 | -14 | N/A | -12 | N/A |
3/31/2014 | 3 | -10 | N/A | -10 | N/A |
12/31/2013 | 3 | -9 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CUL is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CUL is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CUL is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CUL's revenue (30.7% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: CUL's revenue (30.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CUL's Return on Equity is forecast to be high in 3 years time